Efficacy and safety of anti-PD-1/PD-L1 antibodies plus chemotherapy as first-line treatment for non-small cell lung cancer in China: a systematic review and meta-analysis
JTO Clinical and Research Reports（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要